We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

292 hedge funds and large institutions have $10.9B invested in Alnylam Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 83 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 34

37% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 83

4% more funds holding

Funds holding: 282 → 292 (+10)

3% more call options, than puts

Call options by funds: $109M | Put options by funds: $105M

2.24% less ownership

Funds ownership: 93.75% → 91.51% (-2.2%)

7% less capital invested

Capital invested by funds: $11.7B → $10.9B (-$792M)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

Holders
292
Holders Change
+10
Holders Change %
+3.55%
% of All Funds
6.69%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
47
Increased
114
Reduced
83
Closed
34
Calls
$109M
Puts
$105M
Net Calls
+$3.5M
Net Calls Change
-$17.1M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$106M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$54.2M
3
FCM
Farallon Capital Management
California
+$47.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.3M
5
O
OrbiMed
New York
+$41.8M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$456M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$35.2M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$29.4M
4
Goldman Sachs
Goldman Sachs
New York
-$22.8M
5
LCM
Laurion Capital Management
New York
-$15.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
251
Vigilant Capital Management
Maine
$60K – – –
FMLI
252
Fukoku Mutual Life Insurance
Japan
$48K – – –
SWM
253
SeaCrest Wealth Management
New York
$48K – – –
ML
254
McAdam LLC
Pennsylvania
$48K +$51.6K +400 New
US Bancorp
255
US Bancorp
Minnesota
$45K +$16.5K +128 +53%
HIIFS
256
Harel Insurance Investments & Financial Services
Israel
$39K -$12.2K -95 -23%
FPFS
257
First Personal Financial Services
North Carolina
$39K +$9.93K +77 +31%
CFG
258
CKW Financial Group
Hawaii
$30K -$25.8K -200 -40%
DMK
259
David M. Knott
$30K – – –
EDRH
260
Edmond de Rothschild Holding
Switzerland
$25K – – –
SWP
261
Stratos Wealth Partners
Ohio
$24K – – –
TIM
262
Tortoise Investment Management
New York
$24K – – –
AIL
263
AGF Investments LLC
Ontario, Canada
$24K +$13.7K +106 +68%
AIM
264
Anchor Investment Management
South Carolina
$23.8K – – –
GT
265
Glenmede Trust
Pennsylvania
$22K – – –
FANJ
266
Financial Architects (New Jersey)
New Jersey
$17K – – –
SWA
267
Sutton Wealth Advisors
Florida
$16.3K -$8.89K -69 -33%
CAPTRUST Financial Advisors
268
CAPTRUST Financial Advisors
North Carolina
$15K – – –
QCG
269
Quadrant Capital Group
Ohio
$14K +$5.8K +45 +56%
AIM
270
Advantage Investment Management
Iowa
$12K – – –
WAM
271
Wealthspire Advisors (Maryland)
Maryland
$11K +$2.84K +22 +32%
TWMP
272
Taylor Wealth Management Partners
Massachusetts
$10K – – –
PA
273
Parallel Advisors
California
$10K +$1.68K +13 +19%
BAM
274
Bruderman Asset Management
New York
$9K +$9.54K +74 New
ADL
275
Asset Dedication LLC
California
$9K +$9.67K +75 New
9 10
11
12 13

ALNY Hedge Fund Activity: Q1 2018 in Review

292 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2018, worth a combined $10.9B — down 6.8% from $11.7B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 34 closed out — a net gain of 13 holders — while 114 added to existing stakes and 83 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $106M. The largest seller was Dodge & Cox, cutting an estimated $456M.

  • 292 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2018, up from 282 in Q4 2017.
  • Funds reported $10.9B of Alnylam Pharmaceuticals stock for Q1 2018, down 6.8% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2018 and 34 closed out, a net change of +13 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2018 was Point72 Asset Management, an estimated $106M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2018 was Dodge & Cox, an estimated $456M sold.

Based on aggregated 13F filings for Q1 2018.